EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”

The FASEB Journal · 31.05.2026 · 40 (10)

DOI: 10.1096/fj.202602388 ↗

Kurz gefasst

Korrektur in der Zeitschrift The FASEB Journal, online erschienen am 15.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”. The FASEB Journal, 40(10). https://doi.org/10.1096/fj.202602388

Vancouver

Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”. The FASEB Journal. 2026;40(10). doi:10.1096/fj.202602388

BibTeX
@article{euvimed2026,
  title = {Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {10},
  doi = {10.1096/fj.202602388}
}
Kostenlos starten →